{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:53:42Z","timestamp":1793717622645,"version":"4.6.1"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12010-025-05549-x","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:12:02Z","timestamp":1767492722000},"page":"1453-1482","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biomarkers in Disease Diagnosis and Monitoring: Insights into Clinical Applications and Mass Spectrometry-based Detection"],"prefix":"10.1007","volume":"198","author":[{"given":"Shibam","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Kumar","family":"Rawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-8749","authenticated-orcid":false,"given":"Rohit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"5549_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3389\/fpsyt.2020.00432","volume":"11","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2020","unstructured":"Garc\u00eda-Guti\u00e9rrez, M. S., Navarrete, F., Sala, F., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020). Biomarkers in psychiatry: Concept, definition, types and relevance to the clinical reality. Frontiers in Psychiatry, 11, 432. https:\/\/doi.org\/10.3389\/fpsyt.2020.00432","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"5549_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2307\/2394394","volume":"36","author":"BD Mundkur","year":"1949","unstructured":"Mundkur, B. D. (1949). Evidence excluding mutations, polysomy, and polyploidy as possible causes of non-Mendelian segregations in Saccharomyces. Annals of the Missouri Botanical Garden, 36(3), 259. https:\/\/doi.org\/10.2307\/2394394","journal-title":"Annals of the Missouri Botanical Garden"},{"issue":"4","key":"5549_CR3","first-page":"401","volume":"38","author":"KA Porter","year":"1957","unstructured":"Porter, K. A. (1957). Effect of homologous bone marrow injections in X-Irradiated rabbits. British Journal of Experimental Pathology, 38(4), 401\u2013412.","journal-title":"British Journal of Experimental Pathology"},{"key":"5549_CR4","doi-asserted-by":"publisher","unstructured":"Mueller, W. H. (1990). Biological Markers in Epidemiology. Edited by B. S. Hulka, T. C. Wilcosky, and J. D. Griffith. Xi\u2009+\u2009236 Pp. New York: Oxford University Press, $40.00 (Cloth). American J Hum Biol, 1991, 3 (2), 218\u2013219. https:\/\/doi.org\/10.1002\/ajhb.1310030225","DOI":"10.1002\/ajhb.1310030225"},{"issue":"39","key":"5549_CR5","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.2174\/1381612827666210406151447","volume":"27","author":"K Aryutova","year":"2021","unstructured":"Aryutova, K., Stoyanov, D. S., Kandilarova, S., Todeva-Radneva, A., & Kostianev, S. S. (2021). Clinical use of neurophysiological biomarkers and self-assessment scales to predict and monitor treatment response for psychotic and affective disorders. CPD, 27(39), 4039\u20134048. https:\/\/doi.org\/10.2174\/1381612827666210406151447","journal-title":"CPD"},{"issue":"3","key":"5549_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/1535370217750088","volume":"243","author":"RM Califf","year":"2018","unstructured":"Califf, R. M. (2018). Biomarker definitions and their applications. Experimental Biology and Medicine (Maywood, N.J.), 243(3), 213\u2013221. https:\/\/doi.org\/10.1177\/1535370217750088","journal-title":"Experimental Biology and Medicine (Maywood, N.J.)"},{"issue":"6","key":"5549_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu, K., & Tavel, J. A. (2010). What are biomarkers? Current Opinion in Hiv and Aids, 5(6), 463\u2013466. https:\/\/doi.org\/10.1097\/COH.0b013e32833ed177","journal-title":"Current Opinion in Hiv and Aids"},{"issue":"4","key":"5549_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrclinonc.2014.202","volume":"12","author":"A De Gramont","year":"2015","unstructured":"De Gramont, A., Watson, S., Ellis, L. M., Rod\u00f3n, J., Tabernero, J., De Gramont, A., & Hamilton, S. R. (2015). Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nature Reviews. Clinical Oncology, 12(4), 197\u2013212. https:\/\/doi.org\/10.1038\/nrclinonc.2014.202","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"6","key":"5549_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/pharmaceutics15061630","volume":"15","author":"A Ahmad","year":"2023","unstructured":"Ahmad, A., Imran, M., & Ahsan, H. (2023). Biomarkers as biomedical bioindicators: Approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics, 15(6), 1630. https:\/\/doi.org\/10.3390\/pharmaceutics15061630","journal-title":"Pharmaceutics"},{"issue":"1","key":"5549_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13073-020-00820-8","volume":"13","author":"JK Dennis","year":"2021","unstructured":"Dennis, J. K., Sealock, J. M., Straub, P., Lee, Y. H., Hucks, D., Actkins, K., Faucon, A., Feng, Y. C. A., Ge, T., Goleva, S. B., et al. (2021). Clinical laboratory Test-Wide association scan of polygenic scores identifies biomarkers of complex disease. Genome Medicine, 13(1), 6. https:\/\/doi.org\/10.1186\/s13073-020-00820-8","journal-title":"Genome Medicine"},{"issue":"1","key":"5549_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12995-018-0186-9","volume":"13","author":"LT Budnik","year":"2018","unstructured":"Budnik, L. T., Adam, B., Albin, M., Banelli, B., Baur, X., Belpoggi, F., Bolognesi, C., Broberg, K., Gustavsson, P., G\u00f6en, T., et al. (2018). Diagnosis, monitoring and prevention of exposure-Related Non-Communicable diseases in the living and working environment: DiMoPEx-Project is designed to determine the impacts of environmental exposure on human health. Journal of Occupational Medicine and Toxicology, 13(1), 6. https:\/\/doi.org\/10.1186\/s12995-018-0186-9","journal-title":"Journal of Occupational Medicine and Toxicology"},{"issue":"5","key":"5549_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/009286150704100504","volume":"41","author":"OF Laterza","year":"2007","unstructured":"Laterza, O. F., Hendrickson, R. C., & Wagner, J. A. (2007). Molecular biomarkers. Drug Information Journal, 41(5), 573\u2013585. https:\/\/doi.org\/10.1177\/009286150704100504","journal-title":"Drug Information Journal"},{"issue":"1","key":"5549_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2138\/rmg.2005.59.10","volume":"59","author":"JJ Brocks","year":"2005","unstructured":"Brocks, J. J. (2005). Building the biomarker tree of life. Reviews in Mineralogy and Geochemistry, 59(1), 233\u2013258. https:\/\/doi.org\/10.2138\/rmg.2005.59.10","journal-title":"Reviews in Mineralogy and Geochemistry"},{"key":"5549_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.trac.2017.12.015","volume":"100","author":"O Aizpurua-Olaizola","year":"2018","unstructured":"Aizpurua-Olaizola, O., Sastre Tora\u00f1o, J., Falcon-Perez, J. M., Williams, C., Reichardt, N., & Boons, G. J. (2018). Mass spectrometry for glycan biomarker discovery. TrAC - Trends in Analytical Chemistry, 100, 7\u201314. https:\/\/doi.org\/10.1016\/j.trac.2017.12.015","journal-title":"TrAC - Trends in Analytical Chemistry"},{"issue":"5","key":"5549_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2174\/138920006777697918","volume":"7","author":"L Ackermann","year":"2006","unstructured":"Ackermann, L., Hale, B. E., & Duffin, J. L. (2006). The role of mass spectrometry in biomarker discovery and measurement. CDM, 7(5), 525\u2013539. https:\/\/doi.org\/10.2174\/138920006777697918","journal-title":"CDM"},{"issue":"1","key":"5549_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mas.20108","volume":"26","author":"K Dettmer","year":"2007","unstructured":"Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007). Mass Spectrometry-Based metabolomics. Mass Spectrometry Reviews, 26(1), 51\u201378. https:\/\/doi.org\/10.1002\/mas.20108","journal-title":"Mass Spectrometry Reviews"},{"key":"5549_CR17","doi-asserted-by":"publisher","unstructured":"Yan, Z., Cheng, C., & Liu, S. (2012). Applications of Mass Spectrometry in Analyses of Steroid Hormones. In Q. A. Xu & T. L. Madden (Eds.), LC-MS in Drug Bioanalysis (pp. 251\u2013286). Springer US. https:\/\/doi.org\/10.1007\/978-1-4614-3828-1_10","DOI":"10.1007\/978-1-4614-3828-1_10"},{"issue":"8","key":"5549_CR18","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1021\/acs.analchem.3c00091","volume":"95","author":"T Rojsajjakul","year":"2023","unstructured":"Rojsajjakul, T., Wu, L., Grady, C. B., Hwang, W. T., Mesaros, C., Lynch, D. R., & Blair, I. A. (2023). Liquid chromatography\u2013Mass spectrometry analysis of frataxin proteoforms in whole blood as biomarkers of the genetic disease friedreich\u2019s ataxia. Analytical Chemistry, 95(8), 4251\u20134260. https:\/\/doi.org\/10.1021\/acs.analchem.3c00091","journal-title":"Analytical Chemistry"},{"key":"5549_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00091","volume":"6","author":"K Dhama","year":"2019","unstructured":"Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, Mohd. I.., Bhatt, P., et al. (2019). Biomarkers in stress related diseases\/disorders: Diagnostic, prognostic, and therapeutic values. Frontiers in Molecular Biosciences, 6, Article 91. https:\/\/doi.org\/10.3389\/fmolb.2019.00091","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"25","key":"5549_CR20","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa012914","volume":"346","author":"A Rosenwald","year":"2002","unstructured":"Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002). The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. New England Journal of Medicine, 346(25), 1937\u20131947. https:\/\/doi.org\/10.1056\/NEJMoa012914","journal-title":"New England Journal of Medicine"},{"key":"5549_CR21","doi-asserted-by":"publisher","unstructured":"Lukas, A., Heinzel, A., & Mayer, B. (2019). Biomarkers for capturing disease pathology as molecular process hyperstructure. March 11, https:\/\/doi.org\/10.1101\/573402","DOI":"10.1101\/573402"},{"issue":"9","key":"5549_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3390\/metabo11090621","volume":"11","author":"P McGranaghan","year":"2021","unstructured":"McGranaghan, P., Kirwan, J. A., Garcia-Rivera, M. A., Pieske, B., Edelmann, F., Blaschke, F., Appunni, S., Saxena, A., Rubens, M., Veledar, E., et al. (2021). Lipid metabolite biomarkers in cardiovascular disease: Discovery and biomechanism translation from human studies. Metabolites, 11(9), 621. https:\/\/doi.org\/10.3390\/metabo11090621","journal-title":"Metabolites"},{"issue":"5","key":"5549_CR23","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/jcm11051215","volume":"11","author":"M Pospelova","year":"2022","unstructured":"Pospelova, M., Krasnikova, V., Fionik, O., Alekseeva, T., Samochernykh, K., Ivanova, N., Trofimov, N., Vavilova, T., Vasilieva, E., Topuzova, M., et al. (2022). Potential molecular biomarkers of central nervous system damage in breast cancer survivors. JCM, 11(5), 1215. https:\/\/doi.org\/10.3390\/jcm11051215","journal-title":"JCM"},{"issue":"5","key":"5549_CR24","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.3390\/tomography9050149","volume":"9","author":"S Chauvie","year":"2023","unstructured":"Chauvie, S., Mazzoni, L. N., & O\u2019Doherty, J. A. (2023). Review on the use of imaging biomarkers in oncology clinical trials: Quality assurance strategies for technical validation. Tomography, 9(5), 1876\u20131902. https:\/\/doi.org\/10.3390\/tomography9050149","journal-title":"Tomography"},{"issue":"D1","key":"5549_CR25","doi-asserted-by":"publisher","first-page":"D1259","DOI":"10.1093\/nar\/gkaa1067","volume":"49","author":"DS Wishart","year":"2021","unstructured":"Wishart, D. S., Bartok, B., Oler, E., Liang, K. Y. H., Budinski, Z., Berjanskii, M., Guo, A., Cao, X., & Wilson, M. (2021). MarkerDB: An online database of molecular biomarkers. Nucleic Acids Research, 49(D1), D1259\u2013D1267. https:\/\/doi.org\/10.1093\/nar\/gkaa1067","journal-title":"Nucleic Acids Research"},{"key":"5549_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.nuclphysa.2005.02.067","volume":"752","author":"SI Ziegler","year":"2005","unstructured":"Ziegler, S. I. (2005). Positron emission tomography: Principles, technology, and recent developments. Nuclear Physics A, 752, 679\u2013687. https:\/\/doi.org\/10.1016\/j.nuclphysa.2005.02.067","journal-title":"Nuclear Physics A"},{"issue":"9","key":"5549_CR27","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/RLI.0000000000000152","volume":"50","author":"H Kim","year":"2015","unstructured":"Kim, H., Park, C. M., Goo, J. M., Wildberger, J. E., & Kauczor, H. U. (2015). Quantitative computed tomography imaging biomarkers in the diagnosis and management of lung cancer. Investigative Radiology, 50(9), 571\u2013583. https:\/\/doi.org\/10.1097\/RLI.0000000000000152","journal-title":"Investigative Radiology"},{"issue":"12","key":"5549_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8120552","volume":"8","author":"CM Ghantous","year":"2020","unstructured":"Ghantous, C. M., Kamareddine, L., Farhat, R., Zouein, F. A., Mondello, S., Kobeissy, F., & Zeidan, A. (2020). Advances in cardiovascular biomarker discovery. Biomedicines, 8(12), Article 552. https:\/\/doi.org\/10.3390\/biomedicines8120552","journal-title":"Biomedicines"},{"issue":"2","key":"5549_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e13323","volume":"9","author":"A Bodaghi","year":"2023","unstructured":"Bodaghi, A., Fattahi, N., & Ramazani, A. (2023). Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon, 9(2), Article e13323. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13323","journal-title":"Heliyon"},{"issue":"18","key":"5549_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186466","volume":"21","author":"K Sidhom","year":"2020","unstructured":"Sidhom, K., Obi, P. O., & Saleem, A. (2020). A review of exosomal isolation methods: Is size exclusion chromatography the best option? International Journal of Molecular Sciences, 21(18), Article 6466. https:\/\/doi.org\/10.3390\/ijms21186466","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"5549_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/02770903.2022.2051548","volume":"60","author":"V Sharma","year":"2023","unstructured":"Sharma, V., Ricketts, H. C., Steffensen, F., Goodfellow, A., & Cowan, D. C. (2023). Obesity affects type 2 biomarker levels in asthma. Journal of Asthma, 60(2), 385\u2013392. https:\/\/doi.org\/10.1080\/02770903.2022.2051548","journal-title":"Journal of Asthma"},{"issue":"11","key":"5549_CR32","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1007\/s00330-020-06956-w","volume":"30","author":"J Pu","year":"2020","unstructured":"Pu, J., Leader, J., Bandos, A., Shi, J., Du, P., Yu, J., Yang, B., Ke, S., Guo, Y., Field, J. B., et al. (2020). Any unique image biomarkers associated with COVID-19? European Radiology, 30(11), 6221\u20136227. https:\/\/doi.org\/10.1007\/s00330-020-06956-w","journal-title":"European Radiology"},{"issue":"20","key":"5549_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/s22207886","volume":"22","author":"A Velichko","year":"2022","unstructured":"Velichko, A., Huyut, M. T., Belyaev, M., Izotov, Y., & Korzun, D. (2022). Machine learning sensors for diagnosis of COVID-19 disease using routine blood values for Internet of Things application. Sensors, 22(20), Article 7886. https:\/\/doi.org\/10.3390\/s22207886","journal-title":"Sensors"},{"issue":"38","key":"5549_CR34","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.2174\/1381612828666220401142300","volume":"28","author":"S Kalave","year":"2022","unstructured":"Kalave, S., Hegde, N., & Juvale, K. (2022). Applications of nanotechnology-based approaches to overcome multi-drugresistance in cancer. CPD, 28(38), 3140\u20133157. https:\/\/doi.org\/10.2174\/1381612828666220401142300","journal-title":"CPD"},{"issue":"1","key":"5549_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-med-070912-143853","volume":"65","author":"C Paoletti","year":"2014","unstructured":"Paoletti, C., & Hayes, D. F. (2014). Molecular testing in breast cancer. Annual Review of Medicine, 65(1), 95\u2013110. https:\/\/doi.org\/10.1146\/annurev-med-070912-143853","journal-title":"Annual Review of Medicine"},{"issue":"10","key":"5549_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ncponc1187","volume":"5","author":"V Kulasingam","year":"2008","unstructured":"Kulasingam, V., & Diamandis, E. P. (2008). Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nature Reviews. Clinical Oncology, 5(10), 588\u2013599. https:\/\/doi.org\/10.1038\/ncponc1187","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"2","key":"5549_CR37","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/ijms25020794","volume":"25","author":"L Stoicescu","year":"2024","unstructured":"Stoicescu, L., Cri\u015fan, D., Morgovan, C., Avram, L., & Ghibu, S. (2024). Heart failure with preserved ejection fraction: The pathophysiological mechanisms behind the clinical phenotypes and the therapeutic approach. International Journal of Molecular Sciences, 25(2), 794. https:\/\/doi.org\/10.3390\/ijms25020794","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"5549_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.hlc.2016.06.1205","volume":"26","author":"D Stolfo","year":"2017","unstructured":"Stolfo, D., Stenner, E., Merlo, M., Porto, A. G., Moras, C., Barbati, G., Aleksova, A., Buiatti, A., & Sinagra, G. (2017). Prognostic impact of BNP variations in patients admitted for acute decompensated heart failure with In-Hospital worsening renal function. Heart, Lung & Circulation, 26(3), 226\u2013234. https:\/\/doi.org\/10.1016\/j.hlc.2016.06.1205","journal-title":"Heart, Lung & Circulation"},{"key":"5549_CR39","doi-asserted-by":"publisher","unstructured":"Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017). 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American college of Cardiology\/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation, 136(6). https:\/\/doi.org\/10.1161\/CIR.0000000000000509","DOI":"10.1161\/CIR.0000000000000509"},{"issue":"5","key":"5549_CR40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1359-6446(04)03353-7","volume":"10","author":"T Dunckley","year":"2005","unstructured":"Dunckley, T., Coon, K. D., & Stephan, D. A. (2005). Discovery and development of biomarkers of neurological disease. Drug Discovery Today, 10(5), 326\u2013334. https:\/\/doi.org\/10.1016\/S1359-6446(04)03353-7","journal-title":"Drug Discovery Today"},{"issue":"11","key":"5549_CR41","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2174\/1567205016666191024141757","volume":"16","author":"X Shi","year":"2019","unstructured":"Shi, X., Xie, B., Xing, Y., & Tang, Y. (2019). Plasma clusterin as a potential biomarker for Alzheimer\u2019s Disease-A systematic review and Meta-Analysis. CAR, 16(11), 1018\u20131027. https:\/\/doi.org\/10.2174\/1567205016666191024141757","journal-title":"CAR"},{"issue":"10","key":"5549_CR42","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","volume":"62","author":"EP Simpson","year":"2004","unstructured":"Simpson, E. P., Henry, Y. K., Henkel, J. S., Smith, R. G., & Appel, S. H. (2004). Increased lipid peroxidation in Sera of ALS patients: A potential biomarker of disease burden. Neurology, 62(10), 1758\u20131765. https:\/\/doi.org\/10.1212\/WNL.62.10.1758","journal-title":"Neurology"},{"issue":"10","key":"5549_CR43","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1212\/01.wnl.0000244466.46020.47","volume":"67","author":"S Cronin","year":"2006","unstructured":"Cronin, S., Greenway, M. J., Ennis, S., Kieran, D., Green, A., Prehn, J. H. M., & Hardiman, O. (2006). Elevated serum angiogenin levels in ALS. Neurology, 67(10), 1833\u20131836. https:\/\/doi.org\/10.1212\/01.wnl.0000244466.46020.47","journal-title":"Neurology"},{"issue":"4","key":"5549_CR44","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3343\/alm.2021.41.4.355","volume":"41","author":"SY Cho","year":"2021","unstructured":"Cho, S. Y., & Hur, M. (2021). Hepcidin-25 as a novel kidney biomarker for cardiac Surgery-Associated acute kidney injury. Annals of Laboratory Medicine, 41(4), 355\u2013356. https:\/\/doi.org\/10.3343\/alm.2021.41.4.355","journal-title":"Annals of Laboratory Medicine"},{"issue":"8","key":"5549_CR45","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1177\/0192623320964391","volume":"48","author":"\u00c5 Sandelius","year":"2020","unstructured":"Sandelius, \u00c5., Basak, J., H\u00f6ltt\u00e4, M., Sultana, S., Hyberg, G., Wilson, A., Andersson, P., & S\u00f6derberg, M. (2020). Urinary kidney biomarker panel detects preclinical antisense oligonucleotide-induced tubular toxicity. Toxicologic Pathology, 48(8), 981\u2013993. https:\/\/doi.org\/10.1177\/0192623320964391","journal-title":"Toxicologic Pathology"},{"issue":"6","key":"5549_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/children5060064","volume":"5","author":"I Arsik","year":"2018","unstructured":"Arsik, I., Frediani, J., Frezza, D., Chen, W., Ayer, T., Keskinocak, P., Jin, R., Konomi, J., Barlow, S., Xanthakos, S., et al. (2018). Alanine aminotransferase as a monitoring biomarker in children with nonalcoholic fatty liver disease: A secondary analysis using TONIC trial data. Children, 5(6), Article 64. https:\/\/doi.org\/10.3390\/children5060064","journal-title":"Children"},{"key":"5549_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cca.2014.02.021","volume":"433","author":"OA Gressner","year":"2014","unstructured":"Gressner, O. A., & Gao, C. (2014). Monitoring fibrogenic progression in the liver. Clinica Chimica Acta, 433, 111\u2013122. https:\/\/doi.org\/10.1016\/j.cca.2014.02.021","journal-title":"Clinica Chimica Acta"},{"key":"5549_CR48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clinbiochem.2020.01.003","volume":"77","author":"M Paquette","year":"2020","unstructured":"Paquette, M., Gauthier, D., Chamberland, A., Prat, A., De Lucia Rolfe, E., Rasmussen, J. J., Kaduka, L., Seidah, N. G., Bernard, S., Christensen, D. L., et al. (2020). Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis. Clinical Biochemistry, 77, 20\u201325. https:\/\/doi.org\/10.1016\/j.clinbiochem.2020.01.003","journal-title":"Clinical Biochemistry"},{"issue":"2","key":"5549_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10930-009-9227-7","volume":"29","author":"G Maccarrone","year":"2010","unstructured":"Maccarrone, G., Turck, C. W., & Martins-de-Souza, D. (2010). Shotgun Mass Spectrometry Workflow Combining IEF and LC-MALDI-TOF\/TOF. Protein Journal, 29(2), 99\u2013102. https:\/\/doi.org\/10.1007\/s10930-009-9227-7","journal-title":"Protein Journal"},{"issue":"1","key":"5549_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1021\/pr1008515","volume":"10","author":"S Surinova","year":"2011","unstructured":"Surinova, S., Schiess, R., H\u00fcttenhain, R., Cerciello, F., Wollscheid, B., & Aebersold, R. (2011). On the development of plasma protein biomarkers. Journal of Proteome Research, 10(1), 5\u201316. https:\/\/doi.org\/10.1021\/pr1008515","journal-title":"Journal of Proteome Research"},{"issue":"8","key":"5549_CR51","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai, N., Gillette, M. A., & Carr, S. A. (2006). Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nature Biotechnology, 24(8), 971\u2013983. https:\/\/doi.org\/10.1038\/nbt1235","journal-title":"Nature Biotechnology"},{"issue":"4","key":"5549_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1074\/mcp.M500006-MCP200","volume":"4","author":"TD Veenstra","year":"2005","unstructured":"Veenstra, T. D., Conrads, T. P., Hood, B. L., Avellino, A. M., Ellenbogen, R. G., & Morrison, R. S. (2005). Biomarkers: Mining the biofluid proteome. Molecular & Cellular Proteomics, 4(4), 409\u2013418. https:\/\/doi.org\/10.1074\/mcp.M500006-MCP200","journal-title":"Molecular & Cellular Proteomics"},{"issue":"4","key":"5549_CR53","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.molonc.2014.03.006","volume":"8","author":"CE Parker","year":"2014","unstructured":"Parker, C. E., & Borchers, C. H. (2014). Mass spectrometry based biomarker discovery, verification, and validation \u2014 Quality assurance and control of protein biomarker assays. Molecular Oncology, 8(4), 840\u2013858. https:\/\/doi.org\/10.1016\/j.molonc.2014.03.006","journal-title":"Molecular Oncology"},{"key":"5549_CR54","doi-asserted-by":"publisher","unstructured":"Wu, C., Liu, T., Baker, E. S., Rodland, K. D., & Smith, R. D. (2014). Mass Spectrometry for Biomarker Development. In V. R. Preedy & V. B. Patel (Eds.), General Methods in Biomarker Research and their Applications (pp. 1\u201325). Springer Netherlands. https:\/\/doi.org\/10.1007\/978-94-007-7740-8_21-1","DOI":"10.1007\/978-94-007-7740-8_21-1"},{"issue":"12","key":"5549_CR55","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1074\/mcp.M400129-MCP200","volume":"3","author":"PL Ross","year":"2004","unstructured":"Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., et al. (2004). Multiplexed protein quantitation in Saccharomyces cerevisiae using Amine-Reactive isobaric tagging reagents. Molecular & Cellular Proteomics, 3(12), 1154\u20131169. https:\/\/doi.org\/10.1074\/mcp.M400129-MCP200","journal-title":"Molecular & Cellular Proteomics"},{"issue":"5","key":"5549_CR56","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/pmic.200700426","volume":"8","author":"JM Asara","year":"2008","unstructured":"Asara, J. M., Christofk, H. R., Freimark, L. M., & Cantley, L. C. (2008). A label-free quantification method by MS\/MS TIC compared to SILAC and spectral counting in a proteomics screen. Proteomics, 8(5), 994\u2013999. https:\/\/doi.org\/10.1002\/pmic.200700426","journal-title":"Proteomics"},{"issue":"3","key":"5549_CR57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ymeth.2004.08.014","volume":"35","author":"RS Johnson","year":"2005","unstructured":"Johnson, R. S., Davis, M. T., Taylor, J. A., & Patterson, S. D. (2005). Informatics for protein identification by mass spectrometry. Methods, 35(3), 223\u2013236. https:\/\/doi.org\/10.1016\/j.ymeth.2004.08.014","journal-title":"Methods"},{"issue":"3","key":"5549_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nmeth725","volume":"1","author":"RG Sadygov","year":"2004","unstructured":"Sadygov, R. G., Cociorva, D., & Yates, J. R. (2004). Large-scale database searching using tandem mass spectra: Looking up the answer in the back of the book. Nature Methods, 1(3), 195\u2013202. https:\/\/doi.org\/10.1038\/nmeth725","journal-title":"Nature Methods"},{"issue":"7","key":"5549_CR59","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41582-020-0362-2","volume":"16","author":"KD Davis","year":"2020","unstructured":"Davis, K. D., Aghaeepour, N., Ahn, A. H., Angst, M. S., Borsook, D., Brenton, A., Burczynski, M. E., Crean, C., Edwards, R., Gaudilliere, B., et al. (2020). Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: Challenges and opportunities. Nature Reviews Neurology, 16(7), 381\u2013400. https:\/\/doi.org\/10.1038\/s41582-020-0362-2","journal-title":"Nature Reviews Neurology"},{"issue":"4","key":"5549_CR60","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jtho.2021.01.1616","volume":"16","author":"F-S Ou","year":"2021","unstructured":"Ou, F.-S., Michiels, S., Shyr, Y., Adjei, A. A., & Oberg, A. L. (2021). Biomarker discovery and validation: Statistical considerations. Journal of Thoracic Oncology, 16(4), 537\u2013545. https:\/\/doi.org\/10.1016\/j.jtho.2021.01.1616","journal-title":"Journal of Thoracic Oncology"},{"issue":"20","key":"5549_CR61","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.1039\/c8an01017j","volume":"143","author":"KE Yannell","year":"2018","unstructured":"Yannell, K. E., Ferreira, C. R., Tichy, S. E., & Cooks, R. G. (2018). Multiple reaction monitoring (MRM)-profiling with biomarker identification by LC-QTOF to characterize coronary artery disease. Analyst, 143(20), 5014\u20135022. https:\/\/doi.org\/10.1039\/c8an01017j","journal-title":"Analyst"},{"key":"5549_CR62","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ymeth.2015.04.001","volume":"81","author":"AJ Percy","year":"2015","unstructured":"Percy, A. J., Yang, J., Hardie, D. B., Chambers, A. G., Tamura-Wells, J., & Borchers, C. H. (2015). Precise quantitation of 136 urinary proteins by LC\/MRM-MS using stable isotope labeled peptides as internal standards for biomarker discovery and\/or verification studies. Methods, 81, 24\u201333. https:\/\/doi.org\/10.1016\/j.ymeth.2015.04.001","journal-title":"Methods"},{"issue":"11","key":"5549_CR63","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1586\/14737159.2015.1093937","volume":"15","author":"G Mermelekas","year":"2015","unstructured":"Mermelekas, G., Vlahou, A., & Zoidakis, J. (2015). SRM\/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine. Expert Review of Molecular Diagnostics, 15(11), 1441\u20131454. https:\/\/doi.org\/10.1586\/14737159.2015.1093937","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"5549_CR64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jprot.2012.11.005","volume":"81","author":"S Gallien","year":"2013","unstructured":"Gallien, S., Duriez, E., Demeure, K., & Domon, B. (2013). Selectivity of LC-MS\/MS analysis: Implication for proteomics experiments. Journal of Proteomics, 81, 148\u2013158. https:\/\/doi.org\/10.1016\/j.jprot.2012.11.005","journal-title":"Journal of Proteomics"},{"issue":"9","key":"5549_CR65","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.3390\/molecules26092674","volume":"26","author":"J Ryu","year":"2021","unstructured":"Ryu, J., & Thomas, S. N. (2021). Quantitative mass spectrometry-based proteomics for biomarker development in ovarian cancer. Molecules, 26(9), 2674. https:\/\/doi.org\/10.3390\/molecules26092674","journal-title":"Molecules"},{"issue":"1","key":"5549_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12014-015-9102-9","volume":"13","author":"CA Crutchfield","year":"2016","unstructured":"Crutchfield, C. A., Thomas, S. N., Sokoll, L. J., & Chan, D. W. (2016). Advances in mass spectrometry-based clinical biomarker discovery. Clinical Proteomics, 13(1), 1. https:\/\/doi.org\/10.1186\/s12014-015-9102-9","journal-title":"Clinical Proteomics"},{"issue":"2","key":"5549_CR67","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/jnc.15465","volume":"159","author":"M Korecka","year":"2021","unstructured":"Korecka, M., & Shaw, L. M. (2021). Mass spectrometry-based methods for robust measurement of Alzheimer\u2019s disease biomarkers in biological fluids. Journal of Neurochemistry, 159(2), 211\u2013233. https:\/\/doi.org\/10.1111\/jnc.15465","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"5549_CR68","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-190714","volume":"73","author":"X Wang","year":"2020","unstructured":"Wang, X., Sun, Y., Li, T., Cai, Y., & Han, Y. (2020). Amyloid-\u03b2 as a blood biomarker for Alzheimer\u2019s disease: A review of recent literature. Journal of Alzheimer\u2019s Disease, 73(3), 819\u2013832. https:\/\/doi.org\/10.3233\/JAD-190714","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2","key":"5549_CR69","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/brain\/awaa403","volume":"144","author":"A Keshavan","year":"2021","unstructured":"Keshavan, A., Pannee, J., Karikari, T. K., Rodriguez, J. L., Ashton, N. J., Nicholas, J. M., Cash, D. M., Coath, W., Lane, C. A., Parker, T. D., et al. (2021). Population-Based blood screening for preclinical alzheimer\u2019s disease in a British birth cohort at age 70. Brain, 144(2), 434\u2013449. https:\/\/doi.org\/10.1093\/brain\/awaa403","journal-title":"Brain"},{"issue":"3","key":"5549_CR70","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3233\/JAD-200475","volume":"77","author":"YY Lim","year":"2020","unstructured":"Lim, Y. Y., Maruff, P., Kaneko, N., Doecke, J., Fowler, C., Villemagne, V. L., Kato, T., Rowe, C. C., Arahata, Y., Iwamoto, S., et al. (2020). Plasma Amyloid-\u03b2 biomarker associated with cognitive decline in preclinical Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease, 77(3), 1057\u20131065. https:\/\/doi.org\/10.3233\/JAD-200475","journal-title":"Journal of Alzheimer's Disease"},{"issue":"6","key":"5549_CR71","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1373\/clinchem.2013.202937","volume":"59","author":"JH Kang","year":"2013","unstructured":"Kang, J. H., Korecka, M., Toledo, J. B., Trojanowski, J. Q., & Shaw, L. M. (2013). Clinical utility and analytical challenges in measurement of cerebrospinal fluid Amyloid-\u03921\u201342 and \u03c4 proteins as Alzheimer disease biomarkers. Clinical Chemistry, 59(6), 903\u2013916. https:\/\/doi.org\/10.1373\/clinchem.2013.202937","journal-title":"Clinical Chemistry"},{"key":"5549_CR72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3389\/fnagi.2019.00121","volume":"11","author":"NR Barth\u00e9lemy","year":"2019","unstructured":"Barth\u00e9lemy, N. R., Mallipeddi, N., Moiseyev, P., Sato, C., & Bateman, R. J. (2019). Tau phosphorylation rates measured by mass spectrometry differ in the intracellular brain vs. Extracellular cerebrospinal fluid compartments and are differentially affected by Alzheimer\u2019s disease. Frontiers in Aging Neuroscience, 11, 121. https:\/\/doi.org\/10.3389\/fnagi.2019.00121","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"5549_CR73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","volume":"12","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy, N. R., Bateman, R. J., Hirtz, C., Marin, P., Becher, F., Sato, C., Gabelle, A., & Lehmann, S. (2020). Cerebrospinal fluid Phospho-Tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET Amyloid-Positive patient identification. Alzheimer\u2019s Research & Therapy, 12(1), 26. https:\/\/doi.org\/10.1186\/s13195-020-00596-4","journal-title":"Alzheimer's Research & Therapy"},{"issue":"11","key":"5549_CR74","doi-asserted-by":"publisher","first-page":"e20200861","DOI":"10.1084\/jem.20200861","volume":"217","author":"NR Barth\u00e9lemy","year":"2020","unstructured":"Barth\u00e9lemy, N. R., Horie, K., Sato, C., & Bateman, R. J. (2020). Blood plasma Phosphorylated-Tau isoforms track CNS change in Alzheimer\u2019s disease. Journal of Experimental Medicine, 217(11), e20200861. https:\/\/doi.org\/10.1084\/jem.20200861","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"5549_CR75","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze, S., Niklas, M., Palmqvist, S., Smith, R., Beach, T. G., Serrano, G. E., Chai, X., Proctor, N. K., Eichenlaub, U., Zetterberg, H., et al. (2020). Plasma P-Tau181 in Alzheimer\u2019s disease: Relationship to other Biomarkers, differential Diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nature Medicine, 26(3), 379\u2013386. https:\/\/doi.org\/10.1038\/s41591-020-0755-1","journal-title":"Nature Medicine"},{"issue":"3","key":"5549_CR76","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","volume":"26","author":"EH Thijssen","year":"2020","unstructured":"Thijssen, E. H., La Joie, R., Wolf, A., Strom, A., Wang, P., Iaccarino, L., Bourakova, V., Cobigo, Y., Heuer, H., Spina, S., et al. (2020). Diagnostic value of plasma phosphorylated Tau181 in Alzheimer\u2019s disease and frontotemporal Lobar degeneration. Nature Medicine, 26(3), 387\u2013397. https:\/\/doi.org\/10.1038\/s41591-020-0762-2","journal-title":"Nature Medicine"},{"issue":"5","key":"5549_CR77","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari, T. K., Pascoal, T. A., Ashton, N. J., Janelidze, S., Benedet, A. L., Rodriguez, J. L., Chamoun, M., Savard, M., Kang, M. S., Therriault, J., et al. (2020). Blood Phosphorylated Tau 181 as a biomarker for Alzheimer\u2019s disease: A diagnostic performance and prediction modelling study using data from four prospective cohorts. The Lancet Neurology, 19(5), 422\u2013433. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5","journal-title":"The Lancet Neurology"},{"issue":"11","key":"5549_CR78","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","volume":"143","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren, N., Janelidze, S., Palmqvist, S., Cullen, N., Svenningsson, A. L., Strandberg, O., Mengel, D., Walsh, D. M., Stomrud, E., Dage, J. L., et al. (2020). Longitudinal plasma P-Tau217 is increased in early stages of Alzheimer\u2019s disease. Brain, 143(11), 3234\u20133241. https:\/\/doi.org\/10.1093\/brain\/awaa286","journal-title":"Brain"},{"issue":"11","key":"5549_CR79","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1093\/brain\/awaa329","volume":"143","author":"CE Teunissen","year":"2020","unstructured":"Teunissen, C. E., Thijssen, E. H., & Verberk, I. M. W. (2020). <article-title update=\"added\">Plasma p-tau217: From \u2018new kid\u2019 to most promising candidate for Alzheimer\u2019s disease blood test. Brain, 143(11), 3170\u20133172. https:\/\/doi.org\/10.1093\/brain\/awaa329","journal-title":"Brain"},{"issue":"8","key":"5549_CR80","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S., Janelidze, S., Quiroz, Y. T., Zetterberg, H., Lopera, F., Stomrud, E., Su, Y., Chen, Y., Serrano, G. E., Leuzy, A., et al. (2020). Discriminative accuracy of plasma Phospho-Tau217 for alzheimer disease vs other neurodegenerative disorders. Journal of the American Medical Association, 324(8), 772\u2013781. https:\/\/doi.org\/10.1001\/jama.2020.12134","journal-title":"Journal of the American Medical Association"},{"issue":"17","key":"5549_CR81","doi-asserted-by":"publisher","first-page":"13064","DOI":"10.3390\/ijms241713064","volume":"24","author":"M Inoue","year":"2023","unstructured":"Inoue, M., Suzuki, H., Meno, K., Liu, S., Korenaga, T., & Uchida, K. (2023). Identification of plasma proteins as biomarkers for mild cognitive impairment and Alzheimer\u2019s disease using liquid chromatography\u2013tandem mass spectrometry. International Journal of Molecular Sciences, 24(17), 13064. https:\/\/doi.org\/10.3390\/ijms241713064","journal-title":"International Journal of Molecular Sciences"},{"key":"5549_CR82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/JHC.S107370","volume":"Volume 4","author":"DJ Erstad","year":"2017","unstructured":"Erstad, D. J., & Tanabe, K. K. (2017). Hepatocellular carcinoma: Early-stage management challenges. Journal of Histochemistry and Cytochemistry, Volume 4, 81\u201392. https:\/\/doi.org\/10.2147\/JHC.S107370","journal-title":"Journal of Histochemistry and Cytochemistry"},{"issue":"5","key":"5549_CR83","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2008.08.026","volume":"134","author":"E Holmes","year":"2008","unstructured":"Holmes, E., Wilson, I. D., & Nicholson, J. K. (2008). Metabolic phenotyping in health and disease. Cell, 134(5), 714\u2013717. https:\/\/doi.org\/10.1016\/j.cell.2008.08.026","journal-title":"Cell"},{"issue":"Suppl 1 (Suppl","key":"5549_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.8551","volume":"34","author":"K Nagai","year":"2020","unstructured":"Nagai, K., Uranbileg, B., Chen, Z., Fujioka, A., Yamazaki, T., Matsumoto, Y., Tsukamoto, H., Ikeda, H., Yatomi, Y., Chiba, H., et al. (2020). Identification of novel biomarkers of hepatocellular carcinoma by high-definition mass spectrometry: Ultrahigh-performance liquid chromatography quadrupole time-of-flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging. Rapid Communications in Mass Spectrometry, 34(Suppl 1 (Suppl 1)), Article e8551. https:\/\/doi.org\/10.1002\/rcm.8551","journal-title":"Rapid Communications in Mass Spectrometry"},{"key":"5549_CR85","doi-asserted-by":"publisher","first-page":"117302","DOI":"10.1016\/j.cca.2023.117302","volume":"543","author":"Z Liu","year":"2023","unstructured":"Liu, Z., Liu, H., Chen, Z., Deng, C., Zhou, L., Chen, S., Kang, J., Chen, Y., He, S., & Zhou, Z. (2023). Identification of a novel plasma metabolite panel as diagnostic biomarker for hepatocellular carcinoma. Clinica Chimica Acta, 543, 117302. https:\/\/doi.org\/10.1016\/j.cca.2023.117302","journal-title":"Clinica Chimica Acta"},{"issue":"1","key":"5549_CR86","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/metabo13010090","volume":"13","author":"Z Yue","year":"2023","unstructured":"Yue, Z., Pei, L., Meng, G., Zhang, A., Li, M., Jia, M., Wang, H., & Cao, L. (2023). Simultaneous quantification of serum lipids and their association with type 2 diabetes mellitus-positive hepatocellular cancer. Metabolites, 13(1), 90. https:\/\/doi.org\/10.3390\/metabo13010090","journal-title":"Metabolites"},{"issue":"18","key":"5549_CR87","doi-asserted-by":"publisher","first-page":"15795","DOI":"10.1021\/acsomega.2c00885","volume":"7","author":"T Wu","year":"2022","unstructured":"Wu, T., Zheng, X., Yang, M., Zhao, A., Xiang, H., Chen, T., Jia, W., & Ji, G. (2022). Serum amino acid profiles predict the development of hepatocellular carcinoma in patients with chronic HBV infection. ACS Omega, 7(18), 15795\u201315808. https:\/\/doi.org\/10.1021\/acsomega.2c00885","journal-title":"ACS Omega"},{"issue":"12","key":"5549_CR88","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1194\/jlr.M079012","volume":"58","author":"JA Bowden","year":"2017","unstructured":"Bowden, J. A., Heckert, A., Ulmer, C. Z., Jones, C. M., Koelmel, J. P., Abdullah, L., Ahonen, L., Alnouti, Y., Armando, A. M., Asara, J. M., et al. (2017). Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-metabolites in frozen human plasma. Journal of Lipid Research, 58(12), 2275\u20132288. https:\/\/doi.org\/10.1194\/jlr.M079012","journal-title":"Journal of Lipid Research"},{"key":"5549_CR89","doi-asserted-by":"publisher","first-page":"100138","DOI":"10.1016\/j.jlr.2021.100138","volume":"62","author":"HC K\u00f6feler","year":"2021","unstructured":"K\u00f6feler, H. C., Ahrends, R., Baker, E. S., Ekroos, K., Han, X., Hoffmann, N., Hol\u010dapek, M., Wenk, M. R., & Liebisch, G. (2021). Recommendations for good practice in MS-based lipidomics. Journal of Lipid Research, 62, 100138. https:\/\/doi.org\/10.1016\/j.jlr.2021.100138","journal-title":"Journal of Lipid Research"},{"issue":"9","key":"5549_CR90","doi-asserted-by":"publisher","first-page":"100621","DOI":"10.1016\/j.jlr.2024.100621","volume":"65","author":"D Kopczynski","year":"2024","unstructured":"Kopczynski, D., Ejsing, C. S., McDonald, J. G., Bamba, T., Baker, E. S., Bertrand-Michel, J., Br\u00fcgger, B., Coman, C., Ellis, S. R., Garrett, T. J., et al. (2024). The lipidomics reporting checklist a framework for transparency of lipidomic experiments and repurposing resource data. Journal of Lipid Research, 65(9), 100621. https:\/\/doi.org\/10.1016\/j.jlr.2024.100621","journal-title":"Journal of Lipid Research"},{"issue":"6","key":"5549_CR91","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"2","key":"5549_CR92","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1188\/16.CJON.169-173","volume":"20","author":"J Hartnett","year":"2016","unstructured":"Hartnett, J., Thom, B., & Kline, N. (2016). Caregiver burden in end-stage ovarian cancer. Clinical Journal of Oncology Nursing, 20(2), 169\u2013173. https:\/\/doi.org\/10.1188\/16.CJON.169-173","journal-title":"Clinical Journal of Oncology Nursing"},{"issue":"2","key":"5549_CR93","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canlet.2011.01.026","volume":"303","author":"S Pignata","year":"2011","unstructured":"Pignata, S., Cannella, L., Leopardo, D., Pisano, C., Bruni, G. S., & Facchini, G. (2011). Chemotherapy in epithelial ovarian cancer. Cancer Letters, 303(2), 73\u201383. https:\/\/doi.org\/10.1016\/j.canlet.2011.01.026","journal-title":"Cancer Letters"},{"issue":"2","key":"5549_CR94","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1586\/14737140.8.2.243","volume":"8","author":"CS Chu","year":"2008","unstructured":"Chu, C. S., Kim, S. H., June, C. H., & Coukos, G. (2008). Immunotherapy opportunities in ovarian cancer. Expert Review of Anticancer Therapy, 8(2), 243\u2013257. https:\/\/doi.org\/10.1586\/14737140.8.2.243","journal-title":"Expert Review of Anticancer Therapy"},{"issue":"1","key":"5549_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48992-7","volume":"9","author":"J Guo","year":"2019","unstructured":"Guo, J., Li, X., Zhang, W., Chen, Y., Zhu, S., Chen, L., Xu, R., Lv, Y., Wu, D., & Guo, M. (2019). <article-title update=\"added\">HSP60-regulated mitochondrial proteostasis and protein translation promote tumor growth of ovarian cancer. Scientific Reports, 9(1), Article 12628. https:\/\/doi.org\/10.1038\/s41598-019-48992-7","journal-title":"Scientific Reports"},{"issue":"11","key":"5549_CR96","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.3390\/cancers12113447","volume":"12","author":"HS Ahn","year":"2020","unstructured":"Ahn, H. S., Yeom, J., Yu, J., Kwon, Y. I., Kim, J. H., & Kim, K. (2020). Convergence of plasma metabolomics and proteomics analysis to discover signatures of High-Grade serous ovarian cancer. Cancers, 12(11), 3447. https:\/\/doi.org\/10.3390\/cancers12113447","journal-title":"Cancers"},{"issue":"10","key":"5549_CR97","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3390\/cancers13102300","volume":"13","author":"HS Ahn","year":"2021","unstructured":"Ahn, H. S., Ho, J. Y., Yu, J., Yeom, J., Lee, S., Hur, S. Y., Jung, Y., Kim, K., & Choi, Y. J. (2021). Plasma protein biomarkers associated with higher ovarian cancer risk in BRCA1\/2 carriers. Cancers, 13(10), 2300. https:\/\/doi.org\/10.3390\/cancers13102300","journal-title":"Cancers"},{"issue":"3","key":"5549_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12420","volume":"13","author":"A Vyhl\u00eddalov\u00e1 Kotrbov\u00e1","year":"2024","unstructured":"Vyhl\u00eddalov\u00e1 Kotrbov\u00e1, A., G\u00f6m\u00f6ryov\u00e1, K., Mikulov\u00e1, A., Ple\u0161ingerov\u00e1, H., Slade\u010dek, S., Kravec, M., Hrachovinov\u00e1, \u0160, Pot\u011b\u0161il, D., Dunsmore, G., Bl\u00e9riot, C., et al. (2024). Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer. Journal of Extracellular Vesicles, 13(3), Article e12420. https:\/\/doi.org\/10.1002\/jev2.12420","journal-title":"Journal of Extracellular Vesicles"},{"issue":"16","key":"5549_CR99","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1016\/j.cell.2023.07.004","volume":"186","author":"S Chowdhury","year":"2023","unstructured":"Chowdhury, S., Kennedy, J. J., Ivey, R. G., Murillo, O. D., Hosseini, N., Song, X., Petralia, F., Calinawan, A., Savage, S. R., Berry, A. B., et al. (2023). Proteogenomic analysis of Chemo-Refractory High-Grade serous ovarian cancer. Cell, 186(16), 3476\u20133498e35. https:\/\/doi.org\/10.1016\/j.cell.2023.07.004","journal-title":"Cell"},{"issue":"6","key":"5549_CR100","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1473-3099(20)30138-9","volume":"20","author":"PM Keller","year":"2020","unstructured":"Keller, P. M., & Furrer, H. (2020). Think tuberculosis\u2014but is thinking enough? The Lancet Infectious Diseases, 20(6), 639\u2013640. https:\/\/doi.org\/10.1016\/S1473-3099(20)30138-9","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"5549_CR101","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nrmicro.2018.8","volume":"16","author":"S Gagneux","year":"2018","unstructured":"Gagneux, S. (2018). Ecology and evolution of Mycobacterium tuberculosis. Nature Reviews Microbiology, 16(4), 202\u2013213. https:\/\/doi.org\/10.1038\/nrmicro.2018.8","journal-title":"Nature Reviews Microbiology"},{"issue":"7","key":"5549_CR102","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","volume":"18","author":"G Walzl","year":"2018","unstructured":"Walzl, G., McNerney, R., Du Plessis, N., Bates, M., McHugh, T. D., Chegou, N. N., & Zumla, A. (2018). Tuberculosis: Advances and challenges in development of new diagnostics and biomarkers. The Lancet Infectious Diseases, 18(7), e199\u2013e210. https:\/\/doi.org\/10.1016\/S1473-3099(18)30111-7","journal-title":"The Lancet Infectious Diseases"},{"issue":"13","key":"5549_CR103","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1021\/ac0481001","volume":"77","author":"C Wang","year":"2005","unstructured":"Wang, C., Kong, H., Guan, Y., Yang, J., Gu, J., Yang, S., & Xu, G. (2005). Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on High-Performance liquid Chromatography\/Electrospray mass spectrometry and multivariate statistical analysis. Analytical Chemistry, 77(13), 4108\u20134116. https:\/\/doi.org\/10.1021\/ac0481001","journal-title":"Analytical Chemistry"},{"issue":"5","key":"5549_CR104","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1021\/acsmeasuresciau.2c00019","volume":"2","author":"D Li","year":"2022","unstructured":"Li, D., Yi, J., Han, G., & Qiao, L. (2022). MALDI-TOF mass spectrometry in clinical analysis and research. ACS Measurement Science Au, 2(5), 385\u2013404. https:\/\/doi.org\/10.1021\/acsmeasuresciau.2c00019","journal-title":"ACS Measurement Science Au"},{"issue":"10","key":"5549_CR105","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jms.4257","volume":"53","author":"D Chen","year":"2018","unstructured":"Chen, D., Bryden, W. A., & Fenselau, C. (2018). <article-title update=\"added\">Rapid analysis of ricin using hot acid digestion and MALDI\u2010TOF mass spectrometry. Journal of Mass Spectrometry, 53(10), 1013\u20131017. https:\/\/doi.org\/10.1002\/jms.4257","journal-title":"Journal of Mass Spectrometry"},{"key":"5549_CR106","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.ijms.2018.10.033","volume":"435","author":"D Chen","year":"2019","unstructured":"Chen, D., Bryden, W. A., & Fenselau, C. (2019). Microwave supported hydrolysis prepares Bacillus spores for proteomic analysis. International Journal of Mass Spectrometry, 435, 227\u2013233. https:\/\/doi.org\/10.1016\/j.ijms.2018.10.033","journal-title":"International Journal of Mass Spectrometry"},{"issue":"3\u20134","key":"5549_CR107","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ansa.202000149","volume":"2","author":"C G\u00e9hin","year":"2021","unstructured":"G\u00e9hin, C., & Holman, S. W. (2021). Advances in High-resolution mass spectrometry applied to pharmaceuticals in 2020: A whole new age of information. Analytical Science Advances, 2(3\u20134), 142\u2013156. https:\/\/doi.org\/10.1002\/ansa.202000149","journal-title":"Analytical Science Advances"},{"key":"5549_CR108","doi-asserted-by":"publisher","unstructured":"Lima, N. M., Fernandes, B. L. M., Alves, G. F., de Souza, J. C. Q., Siqueira, M. M., Patr\u00edcia, M., Moreira, O. B. O., Sussulini, A., & de Oliveira, M. A. L. (2022). Mass Spectrometry Applied to Diagnosis, Prognosis, and Therapeutic Targets Identification for the Novel Coronavirus SARS-CoV-2: A Review. Anal Chim Acta, 1195, 339385. https:\/\/doi.org\/10.1016\/j.aca.2021.339385","DOI":"10.1016\/j.aca.2021.339385"},{"issue":"1","key":"5549_CR109","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1038\/s41598-020-64637-6","volume":"10","author":"D Chen","year":"2020","unstructured":"Chen, D., Bryden, W. A., & Wood, R. (2020). Detection of tuberculosis by the analysis of exhaled breath particles with High-Resolution mass spectrometry. Scientific Reports, 10(1), 7647. https:\/\/doi.org\/10.1038\/s41598-020-64637-6","journal-title":"Scientific Reports"},{"issue":"48","key":"5549_CR110","doi-asserted-by":"publisher","first-page":"e32153","DOI":"10.1097\/MD.0000000000032153","volume":"101","author":"YX Li","year":"2022","unstructured":"Li, Y. X., Zheng, K. D., Duan, Y., Liu, H. J., Tang, Y. Q., Wu, J., Lin, D. Z., & Zhang, Z. (2022). Mass Spectrometry-Based identification of new serum biomarkers in patients with latent infection pulmonary tuberculosis. Medicine (Baltimore), 101(48), e32153. https:\/\/doi.org\/10.1097\/MD.0000000000032153","journal-title":"Medicine (Baltimore)"},{"issue":"22","key":"5549_CR111","doi-asserted-by":"publisher","first-page":"13733","DOI":"10.3390\/ijms232213733","volume":"23","author":"AF Fernandes","year":"2022","unstructured":"Fernandes, A. F., Gon\u00e7alves, L. G., Bento, M., Anjo, S. I., Manadas, B., Barroso, C., Villar, M., Macedo, R., Sim\u00f5es, M. J., & Coelho, A. V. (2022). Mass spectrometry-based proteomic and metabolomic profiling of serum samples for discovery and validation of tuberculosis diagnostic biomarker signature. International Journal of Molecular Sciences, 23(22), 13733. https:\/\/doi.org\/10.3390\/ijms232213733","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"5549_CR112","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1038\/s41598-022-12018-6","volume":"12","author":"D Chen","year":"2022","unstructured":"Chen, D., Bryden, N. A., Bryden, W. A., McLoughlin, M., Smith, D., Devin, A. P., Caton, E. R., Haddaway, C. R., Tameris, M., Scriba, T. J., et al. (2022). Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosis. Scientific Reports, 12(1), 7919. https:\/\/doi.org\/10.1038\/s41598-022-12018-6","journal-title":"Scientific Reports"},{"issue":"10","key":"5549_CR113","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3390\/biomedicines12102203","volume":"12","author":"S Maringhini","year":"2024","unstructured":"Maringhini, S., & Zoccali, C. (2024). Chronic kidney disease progression\u2014A challenge. Biomedicines, 12(10), 2203. https:\/\/doi.org\/10.3390\/biomedicines12102203","journal-title":"Biomedicines"},{"issue":"7","key":"5549_CR114","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","volume":"20","author":"A Francis","year":"2024","unstructured":"Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024). Chronic kidney disease and the global public health agenda: An international consensus. Nature Reviews Nephrology, 20(7), 473\u2013485. https:\/\/doi.org\/10.1038\/s41581-024-00820-6","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"5549_CR115","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12325-021-01927-z","volume":"39","author":"M Evans","year":"2022","unstructured":"Evans, M., Lewis, R. D., Morgan, A. R., Whyte, M. B., Hanif, W., Bain, S. C., Davies, S., Dashora, U., Yousef, Z., Patel, D. C., et al. (2022). A narrative review of chronic kidney disease in clinical practice: Current challenges and future perspectives. Advanced Therapeutics, 39(1), 33\u201343. https:\/\/doi.org\/10.1007\/s12325-021-01927-z","journal-title":"Advanced Therapeutics"},{"key":"5549_CR116","doi-asserted-by":"publisher","unstructured":"Luczak, M., Formanowicz, D., Pawliczak, E., Wanic-Kossowska, M., Wykretowicz, A., & Figlerowicz, M. (2011). Chronic kidney Disease-Related Atherosclerosis - Proteomic studies of blood plasma. Proteome Sci, 9(1). https:\/\/doi.org\/10.1186\/1477-5956-9-25","DOI":"10.1186\/1477-5956-9-25"},{"issue":"1","key":"5549_CR117","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12967-014-0378-8","volume":"13","author":"M Luczak","year":"2015","unstructured":"Luczak, M., Formanowicz, D., Marczak, \u0141, Pawliczak, E., Wanic-Kossowska, M., Figlerowicz, M., & Stobiecki, M. (2015). Deeper insight into chronic kidney disease-related atherosclerosis: Comparative proteomic studies of blood plasma using 2DE and mass spectrometry. Journal of Translational Medicine, 13(1), 20. https:\/\/doi.org\/10.1186\/s12967-014-0378-8","journal-title":"Journal of Translational Medicine"},{"issue":"5","key":"5549_CR118","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/metabo11050275","volume":"11","author":"L Marczak","year":"2021","unstructured":"Marczak, L., Idkowiak, J., Tracz, J., Stobiecki, M., Perek, B., Kostka-Jeziorny, K., Tykarski, A., Wanic-Kossowska, M., Borowski, M., Osuch, M., et al. (2021). Mass spectrometry-based lipidomics reveals differential changes in the accumulated lipid classes in chronic kidney disease. Metabolites, 11(5), 275. https:\/\/doi.org\/10.3390\/metabo11050275","journal-title":"Metabolites"},{"key":"5549_CR119","doi-asserted-by":"publisher","unstructured":"Watral, J., Formanowicz, D., Perek, B., Kostka-Jeziorny, K., Podkowi\u0144ska, A., Tykarski, A., & Luczak, M. (2024). Comprehensive proteomics of monocytes indicates oxidative imbalance functionally related to inflammatory response in chronic kidney Disease-Related atherosclerosis. Front Mol Biosci, 11. https:\/\/doi.org\/10.3389\/fmolb.2024.1229648","DOI":"10.3389\/fmolb.2024.1229648"},{"issue":"7","key":"5549_CR120","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nbt.1900","volume":"29","author":"JR Whiteaker","year":"2011","unstructured":"Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L., Trute, M., Sokal, I., Yan, P., Schoenherr, R. M., Zhao, L., Voytovich, U. J., et al. (2011). A targeted proteomics\u2013based pipeline for verification of biomarkers in plasma. Nature Biotechnology, 29(7), 625\u2013634. https:\/\/doi.org\/10.1038\/nbt.1900","journal-title":"Nature Biotechnology"},{"issue":"8","key":"5549_CR121","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41596-021-00566-6","volume":"16","author":"ES Nakayasu","year":"2021","unstructured":"Nakayasu, E. S., Gritsenko, M., Piehowski, P. D., Gao, Y., Orton, D. J., Schepmoes, A. A., Fillmore, T. L., Frohnert, B. I., Rewers, M., Krischer, J. P., et al. (2021). Tutorial: Best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation. Nature Protocols, 16(8), 3737\u20133760. https:\/\/doi.org\/10.1038\/s41596-021-00566-6","journal-title":"Nature Protocols"},{"issue":"11","key":"5549_CR122","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.3390\/molecules29112530","volume":"29","author":"F Zhang","year":"2024","unstructured":"Zhang, F., Shan, S., Fu, C., Guo, S., Liu, C., & Wang, S. (2024). Advanced mass spectrometry-based biomarker identification for metabolomics of diabetes mellitus and its complications. Molecules, 29(11), 2530. https:\/\/doi.org\/10.3390\/molecules29112530","journal-title":"Molecules"},{"issue":"6","key":"5549_CR123","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1210\/clinem\/dgaf159","volume":"110","author":"LA Nierves","year":"2025","unstructured":"Nierves, L. A., Lin, T.-T., Moradian, A., Shen, Q., Sechi, S., MacCoss, M. J., Qu, J., van Eyk, J. E., Hoofnagle, A. N., & Qian, W.-J. (2025). Biomarkers, proteoforms, and mass spectrometry\u2013based assays for diabetes clinical research. The Journal of Clinical Endocrinology & Metabolism, 110(6), 1514\u20131523. https:\/\/doi.org\/10.1210\/clinem\/dgaf159","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"5549_CR124","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.2147\/DMSO.S319895","volume":"14","author":"J Reed","year":"2021","unstructured":"Reed, J., Bain, S., & Kanamarlapudi, V. (2021). A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 14, 3567\u20133602. https:\/\/doi.org\/10.2147\/DMSO.S319895","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"},{"issue":"10","key":"5549_CR125","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/jnci\/96.10.732","volume":"96","author":"C Schmidt","year":"2004","unstructured":"Schmidt, C. (2004). Metabolomics takes its place as latest up-and-coming omic science. JNCI Journal of the National Cancer Institute, 96(10), 732\u2013734. https:\/\/doi.org\/10.1093\/jnci\/96.10.732","journal-title":"JNCI Journal of the National Cancer Institute"},{"issue":"4","key":"5549_CR126","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/mas.21777","volume":"42","author":"M Roverso","year":"2023","unstructured":"Roverso, M., Dogra, R., Visentin, S., Pettenuzzo, S., Cappellin, L., Pastore, P., & Bogialli, S. (2023). Mass spectrometry-based omics technologies for the study of gestational diabetes and the discovery of new biomarkers. Mass Spectrometry Reviews, 42(4), 1424\u20131461. https:\/\/doi.org\/10.1002\/mas.21777","journal-title":"Mass Spectrometry Reviews"},{"issue":"4","key":"5549_CR127","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2337\/db15-0661","volume":"65","author":"L Chen","year":"2016","unstructured":"Chen, L., Cheng, C.-Y., Choi, H., Ikram, M. K., Sabanayagam, C., Tan, G. S. W., Tian, D., Zhang, L., Venkatesan, G., Tai, E. S., et al. (2016). Plasma metabonomic profiling of diabetic retinopathy. Diabetes, 65(4), 1099\u20131108. https:\/\/doi.org\/10.2337\/db15-0661","journal-title":"Diabetes"},{"issue":"6","key":"5549_CR128","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00125-018-4599-x","volume":"61","author":"J Merino","year":"2018","unstructured":"Merino, J., Leong, A., Liu, C.-T., Porneala, B., Walford, G. A., Von Grotthuss, M., Wang, T. J., Flannick, J., Dupuis, J., Levy, D., et al. (2018). Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose. Diabetologia, 61(6), 1315\u20131324. https:\/\/doi.org\/10.1007\/s00125-018-4599-x","journal-title":"Diabetologia"},{"issue":"5","key":"5549_CR129","doi-asserted-by":"publisher","first-page":"e10883","DOI":"10.1371\/journal.pone.0010883","volume":"5","author":"WE Gall","year":"2010","unstructured":"Gall, W. E., Beebe, K., Lawton, K. A., Adam, K. P., Mitchell, M. W., Nakhle, P. J., Ryals, J. A., Milburn, M. V., Nannipieri, M., Camastra, S., et al. (2010). \u03b1-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One, 5(5), e10883. https:\/\/doi.org\/10.1371\/journal.pone.0010883","journal-title":"PLoS One"},{"issue":"1","key":"5549_CR130","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","volume":"20","author":"AG Birhanu","year":"2023","unstructured":"Birhanu, A. G. (2023). Mass spectrometry-based proteomics as an emerging tool in clinical laboratories. Clinical Proteomics, 20(1), 32. https:\/\/doi.org\/10.1186\/s12014-023-09424-x","journal-title":"Clinical Proteomics"},{"issue":"1","key":"5549_CR131","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12014-020-09283-w","volume":"17","author":"A Macklin","year":"2020","unstructured":"Macklin, A., Khan, S., & Kislinger, T. (2020). Recent advances in mass spectrometry based clinical proteomics: Applications to cancer research. Clinical Proteomics, 17(1), 17. https:\/\/doi.org\/10.1186\/s12014-020-09283-w","journal-title":"Clinical Proteomics"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05549-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05549-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:02:28Z","timestamp":1773777748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05549-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":131,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5549"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05549-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6333443\/v1","asserted-by":"object"}]},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"10 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"NIL.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}